These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17447943)

  • 21. Missing data methods for the assessment of surrogate outcomes and treatment mechanisms in clinical trial substudies.
    Galbraith S; Marschner IC; Simes J
    Stat Med; 2006 Feb; 25(3):415-31. PubMed ID: 16217855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating association between behavior, corticosterone, heart rate, and blood pressure in rats using surrogate marker evaluation methodology.
    Tilahun A; Maringwa JT; Geys H; Alonso A; Raeymaekers L; Molenberghs G; Van Den Kieboom G; Drinkenburg P; Bijnens L
    J Biopharm Stat; 2009; 19(1):133-49. PubMed ID: 19127472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying the effect of the surrogate marker by information gain.
    Qu Y; Case M
    Biometrics; 2007 Sep; 63(3):958-62; author reply 962-3. PubMed ID: 17825025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing a surrogate predictive value: a causal inference approach.
    Alonso A; Van der Elst W; Meyvisch P
    Stat Med; 2017 Mar; 36(7):1083-1098. PubMed ID: 27966231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surrogate endpoint validation: statistical elegance versus clinical relevance.
    Green E; Yothers G; Sargent DJ
    Stat Methods Med Res; 2008 Oct; 17(5):477-86. PubMed ID: 18285438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a surrogate marker: validity and efficiency.
    Qu Y
    Stat Med; 2013 May; 32(12):1995-2000. PubMed ID: 23132288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Sertindole Cohort Prospective (SCoP) study: rationale, design and methodology.
    Peuskens J; Tanghøj P; Mittoux A;
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):425-33. PubMed ID: 18384186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of the prentice criteria for surrogate endpoints.
    O'Quigley J; Flandre P
    Biometrics; 2006 Mar; 62(1):297-300. PubMed ID: 16542258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individual- and trial-level surrogacy in colorectal cancer.
    Buyse M; Burzykowski T; Michiels S; Carroll K
    Stat Methods Med Res; 2008 Oct; 17(5):467-75. PubMed ID: 18285439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surrogate endpoints for overall survival in advanced colorectal cancer: a clinician's perspective.
    Piedbois P; Miller Croswell J
    Stat Methods Med Res; 2008 Oct; 17(5):519-27. PubMed ID: 18285441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
    Akhondzadeh S; Gerami M; Noroozian M; Karamghadiri N; Ghoreishi A; Abbasi SH; Rezazadeh SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1810-5. PubMed ID: 18727948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evaluation of multiple surrogate endpoints.
    Xu J; Zeger SL
    Biometrics; 2001 Mar; 57(1):81-7. PubMed ID: 11252622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical evaluation of surrogate markers: validity, efficiency, and sensitivity.
    Qu Y
    Clin Trials; 2013 Oct; 10(5):693-5. PubMed ID: 23988465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing surrogacy from the joint modelling of multivariate longitudinal data and survival: application to clinical trial data on chronic lymphocytic leukaemia.
    Deslandes E; Chevret S
    Stat Med; 2007 Dec; 26(30):5411-21. PubMed ID: 18058850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.